Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Feb;61(2):218–220. doi: 10.1038/bjc.1990.40

Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.

R B Pedley 1, G M Boxer 1, J A Boden 1, P J Southall 1, R H Begent 1, K D Bagshawe 1, J Humm 1, F Searle 1
PMCID: PMC1971400  PMID: 2310674

Abstract

Autoradiography with 125I-labelled antibodies 17-1-A and 11-285-14 (anti-carcinoembryonic antigen) injected singly or together into nude mice carrying two distinct human colorectal cancer xenografts delineates marked changes in distribution and retention of isotope over 72 h, which are relevant to microdosimetry. The antibodies localise independently at low concentrations. Slow accumulation and retention predominantly in membranes of glands and necrotic areas suggest that therapy will succeed best with isotopes whose range, half-life and/or mode of delivery can exploit optimally the greater selectivity of the late retention.

Full text

PDF
219

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begent R. H., Ledermann J. A., Green A. J., Bagshawe K. D., Riggs S. J., Searle F., Keep P. A., Adam T., Dale R. G., Glaser M. G. Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. Br J Cancer. 1989 Sep;60(3):406–412. doi: 10.1038/bjc.1989.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Griffith M. H., Yorke E. D., Wessels B. W., DeNardo G. L., Neacy W. P. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med. 1988 Nov;29(11):1795–1809. [PubMed] [Google Scholar]
  3. Herlyn D., Powe J., Alavi A., Mattis J. A., Herlyn M., Ernst C., Vaum R., Koprowski H. Radioimmunodetection of human tumor xenografts by monoclonal antibodies. Cancer Res. 1983 Jun;43(6):2731–2735. [PubMed] [Google Scholar]
  4. Kozak R. W., Atcher R. W., Gansow O. A., Friedman A. M., Hines J. J., Waldmann T. A. Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy. Proc Natl Acad Sci U S A. 1986 Jan;83(2):474–478. doi: 10.1073/pnas.83.2.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lewis J. C., Boxer G. M., Searle F., Bagshawe K. D. The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts. Tumour Biol. 1984;5(5):255–261. [PubMed] [Google Scholar]
  6. Lewis J. C., Smith P. A., Keep P. A., Boxer G. M. A comparison of the content and immunohistochemical patterns of CEA-like activity in human colorectal tumours and nude mouse xenografts. Exp Pathol. 1983;24(4):227–235. doi: 10.1016/s0232-1513(83)80010-3. [DOI] [PubMed] [Google Scholar]
  7. PRESSMAN D., DAY E. D., BLAU M. The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res. 1957 Oct;17(9):845–850. [PubMed] [Google Scholar]
  8. Pedley R. B., Boden J. A., Boden R. W., Green A., Boxer G. M., Bagshawe K. D. The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model. Br J Cancer. 1989 Oct;60(4):549–554. doi: 10.1038/bjc.1989.311. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES